# Effect of Pioglitazone vs Metformin on Clinical, Biochemical and Hormonal Parameters of Insulin Resistant PCOS

> **NCT07472179** · NA · COMPLETED · sponsor: **Mst.Sumyara Khatun** · enrollment: 60 (actual)

## Conditions studied

- PCOS(Insulin Resistant)

## Interventions

- **DRUG:** Pioglitazone 30 Mg Oral Tablet
- **DRUG:** metformin 500 mg thrice daily

## Key facts

- **NCT ID:** NCT07472179
- **Lead sponsor:** Mst.Sumyara Khatun
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-12
- **Primary completion:** 2025-12-12
- **Final completion:** 2026-02-20
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-03-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07472179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07472179, "Effect of Pioglitazone vs Metformin on Clinical, Biochemical and Hormonal Parameters of Insulin Resistant PCOS". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07472179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*